GOLDMAN SACHS GROUP INC - ECHO THERAPEUTICS INC ownership

ECHO THERAPEUTICS INC's ticker is ECTE and the CUSIP is 27876L206. A total of 18 filers reported holding ECHO THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ECHO THERAPEUTICS INC
ValueSharesWeighting
Q1 2016$28,000
+27.3%
21,728
+42.4%
0.00%
Q4 2015$22,000
-8.3%
15,2570.0%0.00%
Q3 2015$24,000
-22.6%
15,257
-17.2%
0.00%
Q2 2015$31,000
-3.1%
18,416
+23.0%
0.00%
Q1 2015$32,000
+60.0%
14,977
+1.0%
0.00%
Q4 2014$20,00014,8340.00%
Other shareholders
ECHO THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Platinum Management (NY) LLC 829,183$1,285,0004.13%
Geduld E E 25,000$39,0000.04%
VANGUARD GROUP INC 4,862,476$151,279,0000.01%
HighTower Advisors, LLC 193,195$298,0000.00%
Tower Research Capital LLC (TRC) 4,740$7,0000.00%
NORTHERN TRUST CORP 12,493$19,0000.00%
Klingman & Associates, LLC 25$00.00%
GOLDMAN SACHS GROUP INC 15,257$24,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 52,333$81,0000.00%
MSI Financial Services Inc 9$00.00%
View complete list of ECHO THERAPEUTICS INC shareholders